"Using disruptive technologies anchored around human experimental medicine platforms, we hope to decipher cellular and molecular mechanisms that lead to axon degeneration and the selective vulnerability of motor neurons in amyotrophic lateral sclerosis." Bhuvaneish Selveraj
UK DRI Emerging Leader
Having graduated from Anna University, India, with an engineering degree, Dr Bhuvaneish T Selvaraj began his scientific research career completing a PhD in the lab of Prof Sendtner at the University of Wuerzburg, Germany. In 2014, he moved to the University of Edinburgh to undertake his postdoctoral research investigating human stem cell disease modelling of neurodegenerative diseases. In 2020, Dr Selvaraj was awarded the Chancellor’s fellowship, funded by Anne Rowling Regenerative Neurology Clinic, to undertake a research programme that aims to gain greater understanding of the molecular pathomechanisms leading to selective vulnerability of motor neurons in amyotrophic lateral sclerosis. Dr Selvaraj became a UK DRI Emerging Leader in 2021 sponsored by Group Leader Prof Siddharthan Chandran.